Trius Agrees to Purchase Newfoundland Mineral Exploration Assets
Trius Investments Inc. is pleased to announce that its wholly-owned subsidiary (the “Subsidiary”) has entered into an asset purchase agreement (the “Purchase Agreement”) with several arm’s length vendors (collectively, the “Vendors”), pursuant to which the Company has indirectly agreed to purchase a mineral license for the Gander West exploration property in Newfoundland (the “Property”), along … Continue reading Trius Agrees to Purchase Newfoundland Mineral Exploration Assets Continue Reading
Healthpeak Properties, Inc. announced today that its CEO, Tom Herzog, will present at the BofA Securities 2020 Global Real Estate Virtual Conference. About Healthpeak Properties Healthpeak Properties, Inc. is a fully integrated real estate investment trust (REIT) and S&P 500 company. Healthpeak owns and develops high-quality real estate in the three private-pay healthcare asset classes of … 
Kaskela Law LLC announces that it is investigating Patterson Companies, Inc. on behalf of the Company’s stockholders. A securities fraud complaint was filed against Patterson in federal court on behalf of investors who purchased shares of the Company’s stock between June 26, 2013 and February 28, 2018. According to the complaint, during that time period Patterson engaged in a “coordinated … 
Kaskela Law LLC announces that it is investigating Akcea Therapeutics, Inc.on behalf of the company’s shareholders. On August 31, 2020, Akcea announced that it had entered into an agreement to be acquired by Ionis Pharmaceuticals, Inc. (“Ionis”) for $18.15 per share in cash. The firm’s investigation seeks to determine whether Akcea’s directors breached their fiduciary duties in agreeing … 
Pfizer Inc. and BioNTech SE announced preliminary preclinical data in mouse and non-human primate models from their BNT162b2 mRNA-based vaccine program against SARS-CoV-2, the virus that causes COVID-19 disease. In a non-human primate preclinical study, immunization with BNT162b2, a nucleoside-modified messenger RNA (modRNA) candidate, protected rhesus macaques against SARS-CoV-2 infection. The manuscript describing these preclinical data is … 
Kaskela Law LLC announces that it is investigating Aimmune Therapeutics, Inc. on behalf of the company’s shareholders. On August 31, 2020, Aimmune announced that it had entered into an agreement to be acquired by Sociétés des Produits Nestlé, S.A. (“Nestle”) for $34.50 per share in an all-cash transaction. The firm’s investigation seeks to determine whether Aimmune’s directors breached their …